Iovance Biotherapeutics Inc (IOVA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$3.41

Buy

$3.47

arrow-up$0.04 (+1.19%)

Prices updated at 02 May 2026, 00:58 EDT

Prices minimum 15 mins delay

Prices in USD

Iovance Biotherapeutics Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.

NASDAQ

0.89%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$3.50 - $3.34
	$5.63 - $1.64
	-
	1,518.11m
	-
	-
	9,933,825
	2.17
	15,292,416.47
	1.81
	411.94m
	US4622601007
	-1.09
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.